Biohaven Pharmaceutical Holding Net Profit Margin 2016-2022 | BHVN
Current and historical net profit margin for Biohaven Pharmaceutical Holding (BHVN) from 2016 to 2022. Net profit margin can be defined as net Income as a portion of total sales revenue. Biohaven Pharmaceutical Holding net profit margin for the three months ending March 31, 2022 was .
| Biohaven Pharmaceutical Holding Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2022-03-31 |
$0.74B |
$-0.79B |
-107.18% |
| 2021-12-31 |
$0.46B |
$-0.85B |
-182.94% |
| 2021-09-30 |
$0.31B |
$-0.87B |
-281.17% |
| 2021-06-30 |
$0.19B |
$-0.89B |
-467.89% |
| 2021-03-31 |
$0.11B |
$-0.86B |
-802.80% |
| 2020-12-31 |
$0.06B |
$-0.77B |
-1198.44% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$9.948B |
$0.463B |
|
Biohaven Pharmaceutical is a commercial-stage biotechnology company focused on developing, and commercializing products, primarily in the fields of central nervous system diseases, including neurological and rare disorders.
|
